Posted by on Dec 28, 2018 in Coronary artery disease | 0 comments

In a nutshell

This trial aims to test new smart technology for preventing patients who have recently had a heart attack from being readmitted to the hospital. The main outcome to be measured will be time to hospital re-admission within 30 days of discharge. This study is being conducted in Maryland, Massachusetts, and Pennsylvania, in the United States.

The details

Re-admission to the hospital after a heart attack is one of the leading causes of preventable death and healthcare costs. John Hopkins University has developed a new technology (Corrie Digital Health Platform) to try and reduce unexplained hospital admissions after a heart attack. This technology includes a smartphone application, an Apple watch, and a Bluetooth-enabled blood pressure cuff. The purpose of this technology is to help management of heart medications, help self-track vital signs (such as heart rate, blood pressure), to educate about heart disease through articles and animated videos and to coordinate outpatient follow-up appointments.

This study aims to investigate whether or not this technology can reduce the number of re-admissions to the hospital after a heart attack. The main outcome to be measured will be the time to first hospital re-admission within 30 days of discharge.

Who are they looking for?

This study is looking for 950 participants. Patients must be admitted with a heart attack (acute myocardial infarction), must be English-speaking and must have a smartphone.

Patients must not have a visual or hearing impairment that would prevent the use of the intervention. Their illness must not be so severe that they could not participate (e.g. sedated, on a ventilator).

How will it work

In this study, all patients will use the Corrie Digital Health Platform. They will also receive the normal standard of care for patients after a heart attack. They will be compared to patients receiving the historical standard of care for patients with a heart attack.

The time to re-admission within 30 days of discharge will be measured. This information will be collected from hospital administrative databases. Patients will be followed for 30 days.

Clinical trial locations

Locations near 43201, United States (Change):
Please enter zip/postal code and country to help us offer locations near you
Show only recruiting locations
Type:Interventional
Participants:200
Study ID:NCT03760796
Want personalized notifications? Get notified only when trials are matching for you.
(it's free)